Fossa S - Search Results

1

Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study.

Kaye SB, Mead GM, Fossa S, Cullen M, deWit R, Bodrogi I, van Groeningen C, Sylvester R, Collette L, Stenning S, De Prijck L, Lallemand E, deMulder P. Kaye SB, et al. Among authors: fossa s. J Clin Oncol. 1998 Feb;16(2):692-701. doi: 10.1200/JCO.1998.16.2.692. J Clin Oncol. 1998. PMID: 9469359 Clinical Trial.

2

5-Aza-2'-deoxycytidine (NSC 127716) in non-seminomatous testicular cancer. Phase II from the EORTC Early Clinical Trials Cooperative Group and Genito-Urinary Group.

Clavel M, Monfardini S, Fosså S, Smyth J, Renard J, Kaye SB. Clavel M, et al. Among authors: fossa s. Ann Oncol. 1992 May;3(5):399-400. doi: 10.1093/oxfordjournals.annonc.a058216. Ann Oncol. 1992. PMID: 1377488 Free article. Clinical Trial. No abstract available.

3

Comparison of the effects of high dose Estramustine phosphate and mitomycin C on the time to progression and length of survival of patients with progressive, advanced endocrine-independent prostatic cancer: an interim analysis of EORTC-GU Group study no. 30865.

Newling DW, Fossa S, Tunn U, Kurth KH, De Pauw M, Sylvester R. Newling DW, et al. Among authors: fossa s. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):971-5. doi: 10.1016/0960-0760(90)90452-q. J Steroid Biochem Mol Biol. 1990. PMID: 2126739 Clinical Trial.

4

An EORTC phase II study of the efficacy and safety of linomide in the treatment of advanced renal cell carcinoma.

Pawinski A, van Oosterom AT, de Wit R, Fosså S, Croles J, Svedberg A, Lentz MA, de Mulder PH. Pawinski A, et al. Among authors: fossa s. Eur J Cancer. 1997 Mar;33(3):496-9. doi: 10.1016/s0959-8049(97)89028-4. Eur J Cancer. 1997. PMID: 9155538 Clinical Trial.

5

Lobaplatin in advanced urothelial tract tumors. The Genitourinary Group of the European Organization for Research and Treatment of Cancer (EORTC).

Sternberg CN, de Mulder P, Fossa S, Kaye S, Roberts T, Pawinsky A, Daamen S. Sternberg CN, et al. Among authors: fossa s. Ann Oncol. 1997 Jul;8(7):695-6. doi: 10.1023/a:1008269432176. Ann Oncol. 1997. PMID: 9296225 Free article. Clinical Trial. No abstract available.

6

Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis.

Bokemeyer C, Nichols CR, Droz JP, Schmoll HJ, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Kanz L, Einhorn L, Hartmann JT. Bokemeyer C, et al. J Clin Oncol. 2002 Apr 1;20(7):1864-73. doi: 10.1200/JCO.2002.07.062. J Clin Oncol. 2002. PMID: 11919246

7

High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysis.

Beyer J, Stenning S, Gerl A, Fossa S, Siegert W. Beyer J, et al. Among authors: fossa s. Ann Oncol. 2002 Apr;13(4):599-605. doi: 10.1093/annonc/mdf112. Ann Oncol. 2002. PMID: 12056711 Free article.

8

Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors.

Christian JA, Huddart RA, Norman A, Mason M, Fossa S, Aass N, Nicholl EJ, Dearnaley DP, Horwich A. Christian JA, et al. Among authors: fossa s. J Clin Oncol. 2003 Mar 1;21(5):871-7. doi: 10.1200/JCO.2003.05.155. J Clin Oncol. 2003. PMID: 12610187 Review.

9

Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20).

Fosså SD, de Wit R, Roberts JT, Wilkinson PM, de Mulder PH, Mead GM, Cook P, de Prijck L, Stenning S, Aaronson NK, Bottomley A, Collette L; European Organization for Research and Treatment of Cancer Genitourinary Group 30941; Medical Research Council Testicular Cancer Study Group TE20. Fosså SD, et al. J Clin Oncol. 2003 Mar 15;21(6):1107-18. doi: 10.1200/JCO.2003.02.075. J Clin Oncol. 2003. PMID: 12637478

10

Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses.

Oldenburg J, Alfsen GC, Lien HH, Aass N, Waehre H, Fossa SD. Oldenburg J, et al. J Clin Oncol. 2003 Sep 1;21(17):3310-7. doi: 10.1200/JCO.2003.03.184. J Clin Oncol. 2003. PMID: 12947067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,023 results

Search Page